x
Filter:
Filters applied
- Multimedia Library
- Serruys, Patrick WRemove Serruys, Patrick W filter
- Nuis, Rutger-JanRemove Nuis, Rutger-Jan filter
Author
- van Domburg, Ron T2
- van Mieghem, Nicolas M2
- Benitez, Luis M1
- Cruz, Lidsa1
- Dager, Antonio E1
- de Jaegere, Peter P1
- de Jaegere, Peter PT1
- Koudstaal, Peter J1
- Moelker, Adriaan1
- Perez, Sergio1
- Rodés-Cabau, Josep1
- Schultz, Carl J1
- van der Boon, Robert M1
- van der Boon, Robert MA1
- van der Lugt, Aad1
- van Geuns, Robert Jan1
- van Geuns, Robert-Jan1
Multimedia Library
2 Results
- Valvular heart disease
Frequency, Determinants and Prognostic Implications of Infectious Complications After Transcatheter Aortic Valve Implantation
American Journal of CardiologyVol. 112Issue 1p104–110Published online: April 8, 2013- Robert M.A. van der Boon
- Rutger-Jan Nuis
- Luis M. Benitez
- Nicolas M. Van Mieghem
- Sergio Perez
- Lidsa Cruz
- and others
Cited in Scopus: 21In-hospital infection (IHI) after transcatheter aortic valve implantation (TAVI) has received little attention, although it may have a significant effect on outcomes and costs because of prolonged hospital stay. Therefore, the aim of this study was to determine the incidence, type, predictors, and prognostic effects of IHI after TAVI. This study included 298 consecutive patients from 2 centers who underwent TAVI from November 2005 to November 2011. IHI during the hospital stay was defined on the basis of symptoms and signs assessed by the attending physician in the cardiac care unit or medium care unit in combination with all technical examinations performed to confirm infection. - Valvular heart disease
Frequency and Causes of Stroke During or After Transcatheter Aortic Valve Implantation
American Journal of CardiologyVol. 109Issue 11p1637–1643Published online: March 19, 2012- Rutger-Jan Nuis
- Nicolas M. Van Mieghem
- Carl J. Schultz
- Adriaan Moelker
- Robert M. van der Boon
- Robert Jan van Geuns
- and others
Cited in Scopus: 131Transcatheter aortic valve implantation (TAVI) is invariably associated with the risk of clinically manifest transient or irreversible neurologic impairment. We sought to investigate the incidence and causes of clinically manifest stroke during TAVI. A total of 214 consecutive patients underwent TAVI with the Medtronic-CoreValve System from November 2005 to September 2011 at our institution. Stroke was defined according to the Valve Academic Research Consortium recommendations. Its cause was established by analyzing the point of onset of symptoms, correlating the symptoms with the computed tomography-detected defects in the brain, and analyzing the presence of potential coexisting causes of stroke, in addition to a multivariate analysis to determine the independent predictors.